KSP-0243

· Kissei Pharmaceutical Co., Ltd.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for KSP-0243, covering 2025-03-17 to 2025-03-17. Get the full timeline:

Most recent: Clinical Trial Update: An Early Phase 2 Clinical Study of KSP-0243 [Phase 2]